Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Thermo Fisher Scientific (TMO) through the VizualStocks API.
Total revenue from Thermo Fisher's chromatography and mass spectrometry, chemical analysis and electron microscopy businesses, plus related consumables, software and services. It includes sales to other Thermo Fisher segments before consolidation eliminations.
analyticalInstrumentsRevenueManagement-defined operating profit from Thermo Fisher's chromatography, chemical-analysis and electron-microscopy businesses. It excludes acquisition-related intangible amortization, restructuring and specified cost-of-revenue and SG&A adjustments, so it is not GAAP operating income.
analyticalInstrumentsSegmentIncomeThermo Fisher revenue from Asia-Pacific customers, in U.S. dollars.
asiaPacificRevenueThermo Fisher revenue from European customers, in U.S. dollars.
europeRevenueTotal revenue from Thermo Fisher's laboratory products and distribution channel, Patheon drug-development and manufacturing services, and PPD clinical-research services. It includes sales to other Thermo Fisher segments before consolidation eliminations.
laboratoryProductsAndBiopharmaServicesRevenueManagement-defined operating profit from Thermo Fisher's laboratory-products, distribution, pharmaceutical-services and clinical-research businesses. It excludes acquisition-related intangible amortization, restructuring and specified cost-of-revenue and SG&A adjustments, so it is not GAAP operating income.
laboratoryProductsAndBiopharmaServicesSegmentIncomeTotal revenue from Thermo Fisher's biosciences, genetic-sciences and bioproduction businesses, including reagents, instruments and consumables used in research, diagnostics and drug and vaccine manufacturing. It includes sales to other Thermo Fisher segments before consolidation eliminations.
lifeSciencesSolutionsRevenueManagement-defined operating profit from Thermo Fisher's biosciences, genetic-sciences and bioproduction businesses. It excludes acquisition-related intangible amortization, restructuring and specified cost-of-revenue and SG&A adjustments, so it is not GAAP operating income.
lifeSciencesSolutionsSegmentIncomeThermo Fisher revenue from North American customers, in U.S. dollars.
northAmericaRevenueThermo Fisher issuer-defined organic revenue growth, excluding acquisition and currency effects, as a fraction.
organicRevenueGrowthRevenue from customers outside Thermo Fisher's North America, Europe and Asia-Pacific geographic categories. This is a residual customer-location bucket spanning the company's full product and service portfolio, not another operating segment.
otherRegionsRevenueTotal revenue from Thermo Fisher's clinical diagnostics, immunodiagnostics, microbiology, transplant diagnostics and healthcare distribution businesses. Products include test kits, reagents, culture media and instruments, and the total includes intersegment sales before elimination.
specialtyDiagnosticsRevenueManagement-defined operating profit from Thermo Fisher's clinical, immunodiagnostic, microbiology and transplant-diagnostics businesses and healthcare channel. It excludes acquisition-related intangible amortization, restructuring and specified cost-of-revenue and SG&A adjustments, so it is not GAAP operating income.
specialtyDiagnosticsSegmentIncome